Synthesis of QS-21-based immunoadjuvants.

about

Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis

P2860

Q28829361-5ECD6940-F58B-44E5-8EE3-502D831D2DCE

P2860

Synthesis of QS-21-based immunoadjuvants.

Item

http://www.wikidata.org/entity/Q37608887

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Synthesis of QS-21-based immunoadjuvants.

@en

Synthesis of QS-21-based immunoadjuvants.

@nl

type

Item

label

Synthesis of QS-21-based immunoadjuvants.

@en

Synthesis of QS-21-based immunoadjuvants.

@nl

prefLabel

Synthesis of QS-21-based immunoadjuvants.

@en

Synthesis of QS-21-based immunoadjuvants.

@nl

P1476

Synthesis of QS-21-based immunoadjuvants.

@en

P2093

Pengfei Wang

http://www.w3.org/2001/XMLSchema#string

Punith Thogaripally

http://www.w3.org/2001/XMLSchema#string

Qipu Dai

http://www.w3.org/2001/XMLSchema#string

Suzanne M Michalek

http://www.w3.org/2001/XMLSchema#string

P2860

Design and synthesis of potent Quillaja saponin vaccine adjuvants

Role of mitogen-activated protein kinases and NF-kappaB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B

Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.

Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.

Unmet needs in modern vaccinology: adjuvants to improve the immune response.

Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis

Current vaccine adjuvants: an overview of a diverse class.

Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes

Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis.

Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer.

P304

11525-11534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JO402118J

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ping Zhang

P577

2013-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24147602

http://www.w3.org/2001/XMLSchema#string

P932

3937867

http://www.w3.org/2001/XMLSchema#string

Synthesis of QS-21-based immunoadjuvants.

about

P2860

P2860

Synthesis of QS-21-based immunoadjuvants.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932